Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis.

BACKGROUND: Strongyloidiasis may cause a life-threatening disease in immunosuppressed patients. This can only be prevented by effective cure of chronic infections. Direct parasitologic exams are not sensitive enough to prove cure if negative. We used an indirect immune fluorescent antibody test (IFA...

Full description

Bibliographic Details
Main Authors: Zeno Bisoffi, Dora Buonfrate, Andrea Angheben, Marina Boscolo, Mariella Anselmi, Stefania Marocco, Geraldo Monteiro, Maria Gobbo, Giulia Bisoffi, Federico Gobbi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-07-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC3144183?pdf=render